These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 34822559)

  • 1. Gut-Kidney Axis on Chip for Studying Effects of Antibiotics on Risk of Hemolytic Uremic Syndrome by Shiga Toxin-Producing
    Lee Y; Kim MH; Alves DR; Kim S; Lee LP; Sung JH; Park S
    Toxins (Basel); 2021 Nov; 13(11):. PubMed ID: 34822559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Genomics of Shiga Toxin-Producing Escherichia coli Strains Isolated from Pediatric Patients with and without Hemolytic Uremic Syndrome from 2000 to 2016 in Finland.
    Bai X; Ylinen E; Zhang J; Salmenlinna S; Halkilahti J; Saxen H; Narayanan A; Jahnukainen T; Matussek A
    Microbiol Spectr; 2022 Aug; 10(4):e0066022. PubMed ID: 35730965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shiga Toxin-Producing
    Bai X; Mernelius S; Jernberg C; Einemo IM; Monecke S; Ehricht R; Löfgren S; Matussek A
    Front Cell Infect Microbiol; 2018; 8():125. PubMed ID: 29765909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shiga toxin-induced haemolytic uraemic syndrome and the role of antibiotics: a global overview.
    Kakoullis L; Papachristodoulou E; Chra P; Panos G
    J Infect; 2019 Aug; 79(2):75-94. PubMed ID: 31150744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection.
    Bruyand M; Mariani-Kurkdjian P; Gouali M; de Valk H; King LA; Le Hello S; Bonacorsi S; Loirat C
    Med Mal Infect; 2018 May; 48(3):167-174. PubMed ID: 29054297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shiga toxin production and translocation during microaerobic human colonic infection with Shiga toxin-producing E. coli O157:H7 and O104:H4.
    Tran SL; Billoud L; Lewis SB; Phillips AD; Schüller S
    Cell Microbiol; 2014 Aug; 16(8):1255-66. PubMed ID: 24612002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Shigatoxin 1 protective for the development of Shigatoxin 2-related hemolytic uremic syndrome in children? Data from the ItalKid-HUS Network.
    Ardissino G; Possenti I; Vignati C; Daprai L; Capone V; Brigotti M; Luini MV; Consonni D; Montini G
    Pediatr Nephrol; 2020 Oct; 35(10):1997-2001. PubMed ID: 32734345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating true incidence of O157 and non-O157 Shiga toxin-producing Escherichia coli illness in Germany based on notification data of haemolytic uraemic syndrome.
    Kuehne A; Bouwknegt M; Havelaar A; Gilsdorf A; Hoyer P; Stark K; Werber D;
    Epidemiol Infect; 2016 Nov; 144(15):3305-3315. PubMed ID: 27468812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shiga toxin-producing Escherichia coli infection and antibodies against Stx2 and Stx1 in household contacts of children with enteropathic hemolytic-uremic syndrome.
    Ludwig K; Sarkim V; Bitzan M; Karmali MA; Bobrowski C; Ruder H; Laufs R; Sobottka I; Petric M; Karch H; Müller-Wiefel DE
    J Clin Microbiol; 2002 May; 40(5):1773-82. PubMed ID: 11980959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Shiga Toxin-Producing Escherichia coli O157:H7 stx Gene Subtype and Disease Severity, England, 2009-2019.
    Byrne L; Adams N; Jenkins C
    Emerg Infect Dis; 2020 Oct; 26(10):2394-2400. PubMed ID: 32946720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strong association between shiga toxin-producing Escherichia coli O157 and virulence genes stx2 and eae as possible explanation for predominance of serogroup O157 in patients with haemolytic uraemic syndrome.
    Werber D; Fruth A; Buchholz U; Prager R; Kramer MH; Ammon A; Tschäpe H
    Eur J Clin Microbiol Infect Dis; 2003 Dec; 22(12):726-30. PubMed ID: 14614596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Petting zoos as sources of Shiga toxin-producing Escherichia coli (STEC) infections.
    Schlager S; Lepuschitz S; Ruppitsch W; Ableitner O; Pietzka A; Neubauer S; Stöger A; Lassnig H; Mikula C; Springer B; Allerberger F
    Int J Med Microbiol; 2018 Oct; 308(7):927-932. PubMed ID: 30257809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bloody Diarrhea and Shiga Toxin-Producing Escherichia coli Hemolytic Uremic Syndrome in Children: Data from the ItalKid-HUS Network.
    Ardissino G; Vignati C; Masia C; Capone V; Colombo R; Tel F; Daprai L; Testa S; Dodaro A; Paglialonga F; Luini M; Brigotti M; Picicco D; Baldioli C; Pagani F; Ceruti R; Tommasi P; Possenti I; Cresseri D; Consonni D; Montini G; Arghittu M;
    J Pediatr; 2021 Oct; 237():34-40.e1. PubMed ID: 34197890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shiga Toxin-Producing Escherichia coli Infection, Antibiotics, and Risk of Developing Hemolytic Uremic Syndrome: A Meta-analysis.
    Freedman SB; Xie J; Neufeld MS; Hamilton WL; Hartling L; Tarr PI; ; Nettel-Aguirre A; Chuck A; Lee B; Johnson D; Currie G; Talbot J; Jiang J; Dickinson J; Kellner J; MacDonald J; Svenson L; Chui L; Louie M; Lavoie M; Eltorki M; Vanderkooi O; Tellier R; Ali S; Drews S; Graham T; Pang XL
    Clin Infect Dis; 2016 May; 62(10):1251-1258. PubMed ID: 26917812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in children: incidence, risk factors, and clinical outcome.
    Ylinen E; Salmenlinna S; Halkilahti J; Jahnukainen T; Korhonen L; Virkkala T; Rimhanen-Finne R; Nuutinen M; Kataja J; Arikoski P; Linkosalo L; Bai X; Matussek A; Jalanko H; Saxén H
    Pediatr Nephrol; 2020 Sep; 35(9):1749-1759. PubMed ID: 32323005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative genomic analysis of a Shiga toxin-producing Escherichia coli (STEC) O145:H25 associated with a severe pediatric case of hemolytic uremic syndrome in Davidson County, Tennessee, US.
    Guerra JA; Zhang C; Bard JE; Yergeau D; Halasa N; Gómez-Duarte OG
    BMC Genomics; 2020 Aug; 21(1):564. PubMed ID: 32807093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shiga toxin-producing escherichia coli infections in Norway, 1992-2012: characterization of isolates and identification of risk factors for haemolytic uremic syndrome.
    Brandal LT; Wester AL; Lange H; Løbersli I; Lindstedt BA; Vold L; Kapperud G
    BMC Infect Dis; 2015 Aug; 15():324. PubMed ID: 26259588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shiga toxin-producing Escherichia coli (STEC) O22:H8 isolated from cattle reduces E. coli O157:H7 adherence in vitro and in vivo.
    Martorelli L; Albanese A; Vilte D; Cantet R; Bentancor A; Zolezzi G; Chinen I; Ibarra C; Rivas M; Mercado EC; Cataldi A
    Vet Microbiol; 2017 Sep; 208():8-17. PubMed ID: 28888654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-genome characterization of hemolytic uremic syndrome-causing Shiga toxin-producing
    Hua Y; Chromek M; Frykman A; Jernberg C; Georgieva V; Hansson S; Zhang J; Marits AK; Wan C; Matussek A; Bai X
    Virulence; 2021 Dec; 12(1):1296-1305. PubMed ID: 33939581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and epidemiologic subtyping of Shiga toxin-producing Escherichia coli strains isolated from hemolytic uremic syndrome and diarrhea cases in Argentina.
    Rivas M; Miliwebsky E; Chinen I; Roldán CD; Balbi L; García B; Fiorilli G; Sosa-Estani S; Kincaid J; Rangel J; Griffin PM;
    Foodborne Pathog Dis; 2006; 3(1):88-96. PubMed ID: 16602984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.